Waterlily Pharmaceuticals specializes in developing hypoxia-targeted imaging agents for cancer diagnosis and prodrugs for cancer therapy. Our offerings include pimonidazole (Hypoxyprobe), NOTA and DOTA for hypoxia detection and cancer treatment research. We also provide the research compounds like [CAS#: 50-28-2],[CAS#: 979-32-8] and [CAS#:57-83-0]. Please click Products  for details.

Contact Information:

E-mail: waterlilypharmaceutical@gmail.com

Online Store: https://sites.google.com/view/waterlily-herbal/home